Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF and Autologous mPBMCs in Children With Cerebral Palsy
NCT02983708Phase 2Completed
- Sponsor
- Hanyang University
- Start
- Aug 2011
- Primary completion
- Sep 2014
- Modality
- Stem Cell Therapies
01
Overview
Phase 2, randomised, double-blind trial in cerebral palsy (CP) comparing mPBMC Sequence with Placebo Sequence (2 arms). Primary endpoint: Overall improvement as a score changes in GMFM > 4 points at 6 months. Started Aug 2011; status: completed.
02
Drugs
autologous mobilized peripheral blood mononuclear cells
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT02983708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02983708.